Coromandel Inter (COROMANDEL)
CyclicalFairStock Score: 61/100 — STEADY
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹2,095.3 |
| Market Cap | ₹61,705.88 Cr |
| P/E Ratio | 33.78 |
| ROCE | 23.2% |
| ROE | 21.61% |
| Dividend Yield | 0.52% |
| Profit Growth | -24.5% |
| Debt/Equity | 0.11 |
| Sales Growth | 15.9% |
| Free Cash Flow | ₹-174 Cr |
| Promoter Holding | 56.86% |
| 52-Week Range | ₹1,652 — ₹2,499 |
| Sector | Fertilizers & Agrochemicals |
| Book Value | ₹426.42 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
I wear two hats: Buffett’s business quality and Graham’s margin of safety. Coromandel Inter, at ₹2,095.30 and ₹61,706 Cr market cap, is a fertilizer business with a 5-year revenue CAGR of 12.89%, latest quarter sales of ₹8,779 Cr, and net profit of ₹488 Cr. The balance sheet looks sturdy: debt/equity only 0.11, ROE 21.61%, ROCE 23.20%, Altman Z-score 4.81, and Piotroski F-score 7/9. Promoter holding at 56.86% also aligns owners. But the earnings picture is uneven: sales grew 15.90% while profit fell 24.50%, and free cash flow is negative ₹174 Cr. That tells me growth is not converting into bottom-line or cash. Valuation is my biggest pause. P/E 33.78 and P/B 4.91 against book value of ₹426.42 leave no Graham cushion. The Graham Number is ₹829.92, implying a margin of safety of -167.49%; I would be paying a huge premium to intrinsic value as Graham defined it. PEG of 1.66 is not cheap, and the negative EV/EBITDA figure deserves scrutiny. Dividend yield is only 0.52%. FairStock score 61/100, Steady, fits a cyclical fertilizer franchise rather than a fast grower. The stock has ranged from ₹1,652 to ₹2,499 over the past year, so sentiment can swing widely. I like the low debt and returns on capital, but at this price I’d wait for profit growth and FCF to recover before calling it a bargain.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer